PHOENIX, AZ--(Marketwired - November 15, 2016) - Cyrex Laboratories, a clinical laboratory specializing in functional immunology and autoimmune reactivity, has announced the availability of its latest test available to Canadian patients, the Array 12 Pathogen Associated Immune Reactivity Screen. This test examines latent pathogens in the body that may be eliciting an immune response; negatively impacting health long after exposure and acute infection have occurred.
Array 12 assesses the immune load from 29 viral, bacterial, fungal, parasitic and stealth organism antigens that may be latent in the body. The test is able to identify well-known pathogenic antigens -- such as the gingivitis bacteria that contributes to tooth decay, penicillium used to make antibiotics, and giardia parasites found in lakes and streams, to much lesser known pathogens such as the borrelia bacteria transmitted by ticks that causes lupus and cryptosporidium, a parasite identified in instances of municipal water supply contamination.
"With the Array 12 screen, Cyrex is adding a key piece of the environmental triggers puzzle," said Jean Bellin, president of Cyrex Laboratories. "Array 12 is the most thorough test available for environmental triggers related to viral, bacterial, fungal, parasitic and stealth organism pathogens that may be latent in the body. This test offers physicians and patients unparalleled insight into the health of patients who may have fallen ill due to a pathogen encounter years prior to testing, or who may not have even experienced any symptoms and are unaware that any exposure occurred."
Array 12 is available for $379 and is not intended for use as a diagnostic tool to confirm acute infection. Array 12 was developed with proprietary technology to look for IgG antibodies to pathogens that demonstrate immune reactivity long after initial symptoms or exposure occurred.
This panel augments the environmental triggers testing offered at Cyrex; from the extensive foods, food additives and proteins/peptides on Arrays 3, 4 and the 10 series, to assessing reactivity to toxic chemicals and metals on Array 11, now Array 12 completes the environmental trigger puzzle by gauging the ongoing immune response to pathogenic exposure.
Patients who may be suffering from immune reactivity or sensitivity as a result of latent pathogens in their body are encouraged to ask their physicians about Array 12. Also, as with all Cyrex testing, healthcare providers may request a clinical consultation to discuss Array 12 results with a member of our clinical consulting team. Physicians and other licensed healthcare professionals, as well as patients, interested in learning more about Array 12 or any of the Cyrex Arrays that are part of the Cyrex System, are encouraged to visit www.joincyrex.com for additional information.
About Cyrex Laboratories
Cyrex is a clinical immunology laboratory specializing in functional immunology and autoimmune reactivity. Cyrex offers multi-tissue antibody testing for the early detection and monitoring of today's complex autoimmune conditions. Cyrex develops innovative testing arrays through continuous collaboration with leading experts in medical research and clinical practice. Cyrex technology is built on four pillars of excellence, including the antigen purification system, optimized antigen concentration, antigen-specific validation and parallel testing technology. Cyrex is a CLIA licensed laboratory based in Phoenix, Arizona and holds a Medical Device Establishment License in Canada.